Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients
(2024)
Journal Article
Background Epstein barr virus (EBV) infection of B cells is now understood to be one of the triggering events for the development of Multiple Sclerosis (MS), a progressive immune-mediated disease of the central nervous system. EBV infection is also... Read More about Ocrelizumab B cell depletion has no effect on HERV RNA expression in PBMC in MS patients.